Alto Neuroscience Overview
Alto Neuroscience (ANRO) has a P/E ratio of -11.56, below the sector sector average of 47.3.
Get informed when a big investor buys or sells
+ Follow-11.56
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for ANRO is -11.56. That is below the sector sector average of 47.3. Investors often review this figure alongside Alto Neuroscience's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, ANRO currently prints -11.56 for P/E ratio, while the sector average sits near 47.3. That is roughly 124.4% below the sector mean. Large gaps often invite a closer look at Alto Neuroscience's growth, margins, and balance sheet.
A P/E ratio of -11.56 for Alto Neuroscience is not 'good' or 'bad' on its own. Compare it with the peer average (47.3) and with ANRO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting ANRO's P/E ratio (-11.56), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
